Revenue
attach_money124M USD
YoY +63.5%
GLUEMonte Rosa Therapeutics, Inc.$ --
Monte Rosa Therapeutics, Inc.
GLUE
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-54M USD
YoY +33.2%
Net Income
verified-39M USD
YoY +46.9%
EPS
pie_chart-0.46USD
YoY +53.1%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress180.3%On Track
Revenue Progress123.7M
Revenue Forecast136.5M
Net Income Progress-38.6M
Net Income Forecast-21.4M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.